|
ViroPharma Incorporated - Company Profile Snapshot
| Company Profile: |
ViroPharma Incorporated |
| Ticker: |
VPHM |
| Exchanges: |
NAS |
| 2008 Sales: |
232,310,000 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Medical Services |
| Country: |
UNITED STATES |
| Employees: |
201 |
Business Description
ViroPharma Incorporated. The Group's principal activity is to develop and commercialize products that address serious diseases treated by physician specialists, in areas including hospital settings, transplant medicine and gastroenterology. It is focused on the marketing and sale of its commercialized product, Vancocin, an oral capsule to treat antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains. The development activities are currently focused on product candidates to treat viral diseases including those caused by cytomegalovirus (CMV) and hepatitis C (HCV) infections. As on 21-Oct-2008, it acquired Lev Pharmaceuticals Inc.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
